OC)N=C2C1C=CC(Cl)=CC=1](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10038_1621561221.gif?v=1742876709)
ALW-II-41-27 - CAS# 1186206-79-0 Catalog No.:M10038-10 CC1C2=C(SC=1C(=O)NCCCCCNC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N1C(=NN=C1C)[C@H](CC(=O)OC)N=C2C1C=CC(Cl)=CC=1
Pay in 4 interest-free payments of $23.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
ALW-II-41-27 - CAS# 1186206-79-0 Catalog No.:M10038-10 CC1C2=C(SC=1C(=O)NCCCCCNC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N1C(=NN=C1C)[C@H](CC(=O)OC)N=C2C1C=CC(Cl)=CC=1ALW II 41 27 is a Eph receptor tyrosine kinase inhibitor. pharmacologic inhibition of EPHA2 by the small molecule inhibitor ALW II 41 27 decreased both survival and proliferation of erlotinib resistant tumor cells and inhibited tumor growth in vivo. ALW II 41 27 was also effective in decreasing viability of cells with acquired resistance to the third generation EGFR TKI AZD9291. Collectively, these data define a role for EPHA2 in the maintenance of
Store: live-language.pl · Domain: live-language.pl
